MP-424 (Telaprevir)
G060-A7
Phase 2 small_molecule completed
Quick answer
MP-424 (Telaprevir) for Hepatitis C is a Phase 2 program (small_molecule) at VERTEX PHARMACEUTICALS INC / MA with 1 ClinicalTrials.gov record(s).
Program details
- Company
- VERTEX PHARMACEUTICALS INC / MA
- Indication
- Hepatitis C
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed